* Helius Medical Technologies Inc reported a quarterly adjusted loss of 64 cents per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $-3.00. The lone analyst forecast for the quarter was for a loss of 50 cents per share.
* Revenue fell 28.9% to $182.00 thousand from a year ago; analysts expected $150.00 thousand.
* Helius Medical Technologies Inc's reported EPS for the quarter was a loss of 64 cents.
* The company reported a quarterly loss of $1.61 million.
* Helius Medical Technologies Inc shares had fallen by 21.1% this quarter and lost 90.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 77.8% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Helius Medical Technologies Inc is $4.00 This summary was machine generated from LSEG data August 13 at 01:00 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.50 -0.64 Missed
Mar. 31 2024 -3.87 -3.08 Beat
Dec. 31 2023 -3.77 -1.47 Beat
Sep. 30 2023 -6.00 -5.49 Beat
Comments